FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2174830109> ?p ?o ?g. }

• W2174830109 endingPage "84" @default.
• W2174830109 startingPage "84" @default.
• W2174830109 abstract "The prevalence of hepatitis C virus (HCV) in U.S. prisoners is high; however, HCV testing and treatment are rare. Infected inmates released back into society contribute to the spread of HCV in the general population. Routine hepatitis screening of inmates followed by new therapies may reduce ongoing HCV transmission.To evaluate the health and economic effect of HCV screening and treatment in prisons on the HCV epidemic in society.Agent-based microsimulation model of HCV transmission and progression of HCV disease.Published literature.Population in U.S. prisons and general community.30 years.Societal.Risk-based and universal opt-out hepatitis C screening in prisons, followed by treatment in a portion of patients.Prevention of HCV transmission and associated disease in prisons and society, costs, quality-adjusted life-years (QALYs), incremental cost-effectiveness ratio (ICER), and total prison budget.Implementing risk-based and opt-out screening could diagnose 41,900 to 122,700 new HCV cases in prisons in the next 30 years. Compared with no screening, these scenarios could prevent 5500 to 12,700 new HCV infections caused by released inmates, wherein about 90% of averted infections would have occurred outside of prisons. Screening could also prevent 4200 to 11,700 liver-related deaths. The ICERs of screening scenarios were $19,600 to $29,200 per QALY, and the respective first-year prison budget was $900 to $1150 million. Prisons would require an additional 12.4% of their current health care budget to implement such interventions.Results were sensitive to the time horizon, and ICERs otherwise remained less than $50,000 per QALY.Data on transmission network, reinfection rate, and opt-out HCV screening rate are lacking.Universal opt-out HCV screening in prisons is highly cost-effective and would reduce HCV transmission and HCV-associated diseases primarily in the outside community. Investing in U.S. prisons to manage hepatitis C is a strategic approach to address the current epidemic.National Institutes of Health." @default.
• W2174830109 created "2016-06-24" @default.
• W2174830109 creator A5004834248 @default.
• W2174830109 creator A5015941300 @default.
• W2174830109 creator A5038177258 @default.
• W2174830109 creator A5040123651 @default.
• W2174830109 creator A5043740961 @default.
• W2174830109 creator A5066154658 @default.
• W2174830109 creator A5071727813 @default.
• W2174830109 date "2015-11-24" @default.
• W2174830109 modified "2023-10-01" @default.
• W2174830109 title "Prevention of Hepatitis C by Screening and Treatment in U.S. Prisons" @default.
• W2174830109 cites W113277030 @default.
• W2174830109 cites W1600355494 @default.
• W2174830109 cites W162603234 @default.
• W2174830109 cites W1976074649 @default.
• W2174830109 cites W1983489842 @default.
• W2174830109 cites W1986135287 @default.
• W2174830109 cites W1988215365 @default.
• W2174830109 cites W2002830957 @default.
• W2174830109 cites W2004461455 @default.
• W2174830109 cites W2043951092 @default.
• W2174830109 cites W2050918400 @default.
• W2174830109 cites W2054882786 @default.
• W2174830109 cites W2059496327 @default.
• W2174830109 cites W2069705434 @default.
• W2174830109 cites W2072300676 @default.
• W2174830109 cites W2076604478 @default.
• W2174830109 cites W2077227075 @default.
• W2174830109 cites W2078799829 @default.
• W2174830109 cites W2081689022 @default.
• W2174830109 cites W2092646281 @default.
• W2174830109 cites W2114731951 @default.
• W2174830109 cites W2117129614 @default.
• W2174830109 cites W2125963799 @default.
• W2174830109 cites W2130956101 @default.
• W2174830109 cites W2133721686 @default.
• W2174830109 cites W2141214317 @default.
• W2174830109 cites W2148959572 @default.
• W2174830109 cites W2149638499 @default.
• W2174830109 cites W2150704630 @default.
• W2174830109 cites W2162933087 @default.
• W2174830109 cites W2163848297 @default.
• W2174830109 cites W2183900347 @default.
• W2174830109 cites W2325791202 @default.
• W2174830109 doi "https://doi.org/10.7326/m15-0617" @default.
• W2174830109 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4854298" @default.
• W2174830109 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26595252" @default.
• W2174830109 hasPublicationYear "2015" @default.
• W2174830109 type Work @default.
• W2174830109 sameAs 2174830109 @default.
• W2174830109 citedByCount "129" @default.
• W2174830109 countsByYear W21748301092016 @default.
• W2174830109 countsByYear W21748301092017 @default.
• W2174830109 countsByYear W21748301092018 @default.
• W2174830109 countsByYear W21748301092019 @default.
• W2174830109 countsByYear W21748301092020 @default.
• W2174830109 countsByYear W21748301092021 @default.
• W2174830109 countsByYear W21748301092022 @default.
• W2174830109 countsByYear W21748301092023 @default.
• W2174830109 crossrefType "journal-article" @default.
• W2174830109 hasAuthorship W2174830109A5004834248 @default.
• W2174830109 hasAuthorship W2174830109A5015941300 @default.
• W2174830109 hasAuthorship W2174830109A5038177258 @default.
• W2174830109 hasAuthorship W2174830109A5040123651 @default.
• W2174830109 hasAuthorship W2174830109A5043740961 @default.
• W2174830109 hasAuthorship W2174830109A5066154658 @default.
• W2174830109 hasAuthorship W2174830109A5071727813 @default.
• W2174830109 hasBestOaLocation W21748301092 @default.
• W2174830109 hasConcept C118552586 @default.
• W2174830109 hasConcept C119599485 @default.
• W2174830109 hasConcept C126322002 @default.
• W2174830109 hasConcept C127413603 @default.
• W2174830109 hasConcept C159047783 @default.
• W2174830109 hasConcept C166957645 @default.
• W2174830109 hasConcept C2522874641 @default.
• W2174830109 hasConcept C27415008 @default.
• W2174830109 hasConcept C2776408679 @default.
• W2174830109 hasConcept C2776455275 @default.
• W2174830109 hasConcept C2777075537 @default.
• W2174830109 hasConcept C2780656516 @default.
• W2174830109 hasConcept C2908647359 @default.
• W2174830109 hasConcept C512399662 @default.
• W2174830109 hasConcept C71924100 @default.
• W2174830109 hasConcept C761482 @default.
• W2174830109 hasConcept C95457728 @default.
• W2174830109 hasConcept C99454951 @default.
• W2174830109 hasConceptScore W2174830109C118552586 @default.
• W2174830109 hasConceptScore W2174830109C119599485 @default.
• W2174830109 hasConceptScore W2174830109C126322002 @default.
• W2174830109 hasConceptScore W2174830109C127413603 @default.
• W2174830109 hasConceptScore W2174830109C159047783 @default.
• W2174830109 hasConceptScore W2174830109C166957645 @default.
• W2174830109 hasConceptScore W2174830109C2522874641 @default.
• W2174830109 hasConceptScore W2174830109C27415008 @default.
• W2174830109 hasConceptScore W2174830109C2776408679 @default.
• W2174830109 hasConceptScore W2174830109C2776455275 @default.
• W2174830109 hasConceptScore W2174830109C2777075537 @default.

• next